Predictors of Virological Outcome and Safety in Primary HIV Type 1-Infected Patients Initiating Quadruple Antiretroviral Therapy: QUEST GW PROB3005 | Zendy

Bruno Hoen | Zendy; David A. Cooper | Zendy; Fiona Lampe | Zendy; Lionel Perrin | Zendy; Nathan Clumeck | Zendy; Andrew Phillips | Zendy; Lionel Goh | Zendy; Stefan Lindbäck | Zendy; D. Séréni | Zendy; B G Gazzard | Zendy; Joan Montaner | Zendy; HansJuergen Stellbrink | Zendy; Adriano Lazzarin | Zendy; Diane Ponscarme | Zendy; Schlomo Staszewski | Zendy; L Mathiesen | Zendy; Don Smith | Zendy; Robert Finlayson | Zendy; Rainer Weber | Zendy; Lea Wegmann | Zendy; George Janossy | Zendy; Sabine Kinloch-de Loës | Zendy

Open Access

Predictors of Virological Outcome and Safety in Primary HIV Type 1-Infected Patients Initiating Quadruple Antiretroviral Therapy: QUEST GW PROB3005

Author(s) -

Bruno Hoen,

David A. Cooper,

Fiona Lampe,

Lionel Perrin,

Nathan Clumeck,

Andrew Phillips,

Lionel Goh,

Stefan Lindbäck,

D. Séréni,

B G Gazzard,

Joan Montaner,

HansJuergen Stellbrink,

Adriano Lazzarin,

Diane Ponscarme,

Schlomo Staszewski,

L Mathiesen,

Don Smith,

Robert Finlayson,

Rainer Weber,

Lea Wegmann,

George Janossy,

Sabine Kinloch-de Loës

Publication year - 2007

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/519428

Subject(s) - interquartile range , medicine , viral load , peripheral blood mononuclear cell , abacavir , amprenavir , lamivudine , zidovudine , adverse effect , immunology , virology , lentivirus , gastroenterology , antiretroviral therapy , human immunodeficiency virus (hiv) , viral disease , virus , biology , hepatitis b virus , biochemistry , protease , hiv 1 protease , in vitro , enzyme

Initiation of antiretroviral therapy during primary human immunodeficiency virus (HIV)-1 infection may confer long-term benefit.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research